ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,374Medicare Part D Prescriptions Filled, Including Refills

Rank: 726 out of 3647

$441K Total Retail Price of All Prescriptions

Rank: 1334 out of 3647

1,135 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,135 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 650 535 1 4
SIMVASTATIN 599 490 2 1
AMLODIPINE BESYLATE 511 439 3 2
METFORMIN HCL 498 402 4 6
OMEPRAZOLE 470 378 5 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 393 313 6 36
ATORVASTATIN CALCIUM 369 282 7 13
LEVOTHYROXINE SODIUM 355 282 8 5
HYDROCHLOROTHIAZIDE 329 271 9 9
FLUTICASONE PROPIONATE 280 224 10 32
CARVEDILOL 223 157 11 20
WARFARIN SODIUM 217 189 12 15
ATENOLOL 210 165 13 10
GLIMEPIRIDE 197 155 14 45
METOPROLOL TARTRATE 181 140 15 7
LIPITOR 165 143 16 113
METOPROLOL SUCCINATE 163 135 17 18
ALENDRONATE SODIUM 162 153 18 23
GABAPENTIN 154 104 19 17
MELOXICAM 152 111 20 33
CLONIDINE HCL 137 112 21 46
LOSARTAN POTASSIUM 113 103 22 11
PRAVASTATIN SODIUM 112 93 23 16
LOVASTATIN 111 101 24 21
TRAMADOL HCL 107 61 25 22
RANITIDINE HCL 105 84 26 29
FUROSEMIDE 92 68 27 8
ALLOPURINOL 89 81 28 37
LOSARTAN-HYDROCHLOROTHIAZIDE 82 75 29 48
ISOSORBIDE MONONITRATE ER 79 64 30 56
NIFEDIPINE ER 76 58 31 67
PAROXETINE HCL 76 51 31 60
LANTUS 74 45 33 59
GLIPIZIDE 72 51 34 41
TIZANIDINE HCL 71 33 35 126
ATENOLOL-CHLORTHALIDONE 71 71 35 171
HYDRALAZINE HCL 69 57 37 81
DOXAZOSIN MESYLATE 69 63 37 57
PLAVIX 67 56 39 39
ENALAPRIL MALEATE 66 66 40 35
TAMSULOSIN HCL 64 59 41 28
ADVAIR DISKUS 53 38 42 52
FLUOXETINE HCL 50 38 43 68
JANTOVEN 50 50 43 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.